Balsalazide Disodium
5 NDCs across 5 manufacturers|5 Generic,0 Brand
Balsalazide Disodium is used to treat ulcerative colitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 18, 2000, and the first generic was approved Dec 28, 2007. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $19 million on Balsalazide Disodium across 107,000 claims for 24,000 beneficiaries.
Balsalazide Disodium is available as 5 NDCs from 5 manufacturers (5 generic, 0 brand), with NADAC prices from $0.34 to $0.34 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
5G / 0B
Manufacturers
5
competing in market
Price Spread
$0.34 – $0.34
per EA
7d Activity
avg -2.9% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Hikma Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Aminosalicylate class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing BALSALAZIDE DISODIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BALSALAZIDE DISODIUM 750 MG CP | $0.3443 per EA | -2.88% |
BALSALAZIDE DISODIUM 750 MG CP | $0.3443 per EA | -2.88% |
BALSALAZIDE DISODIUM 750 MG CP | $0.3443 per EA | -2.88% |
BALSALAZIDE DISODIUM 750 MG CP | $0.3443 per EA | -2.88% |
BALSALAZIDE DISODIUM 750 MG CP | $0.3443 per EA | -2.88% |
Frequently Asked Questions
What is Balsalazide Disodium used to treat?
Balsalazide Disodium is used to treat ulcerative colitis, per the National Library of Medicine's MED-RT classification.
When did Balsalazide Disodium become available as a generic?
FDA approved the first generic Balsalazide Disodium (ANDA) on Dec 28, 2007. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Balsalazide Disodium?
In 2024, Medicare Part D spent $19 million on Balsalazide Disodium across 107,000 claims for 24,000 beneficiaries.
How many Balsalazide Disodium products are on the market?
The Balsalazide Disodium drug market contains 5 NDCs from 5 manufacturers — 5 generic and 0 brand products.
What is the price range for Balsalazide Disodium?
NADAC reference prices for Balsalazide Disodium range from $0.3443 to $0.3443 per EA.
Which manufacturers make Balsalazide Disodium?
5 manufacturers list Balsalazide Disodium in NADAC. Ranked by number of NDCs, the largest are Hikma Pharmaceuticals USA Inc. (1), AvPAK (1), Apotex Corp. (1), Zydus Pharmaceuticals (USA) Inc. (1), Carnegie Pharmaceuticals LLC (1).
How has the price of Balsalazide Disodium changed recently?
Over the past 7 days, 0 Balsalazide Disodium NDCs rose and 5 fell, with a market-wide average change of -2.9%.